Study on the Stability of Complex Networks in the Stock Markets of Key Industries in China.

Study on the Stability of Complex Networks in the Stock Markets of Key Industries in China.

Publication date: Jun 30, 2024

Investigating the significant “roles” within financial complex networks and their stability is of great importance for preventing financial risks. On one hand, this paper initially constructs a complex network model of the stock market based on mutual information theory and threshold methods, combined with the closing price returns of stocks. It then analyzes the basic topological characteristics of this network and examines its stability under random and targeted attacks by varying the threshold values. On the other hand, using systemic risk entropy as a metric to quantify the stability of the stock market, this paper validates the impact of the COVID-19 pandemic as a widespread, unexpected event on network stability. The research results indicate that this complex network exhibits small-world characteristics but cannot be strictly classified as a scale-free network. In this network, key roles are played by the industrial sector, media and information services, pharmaceuticals and healthcare, transportation, and utilities. Upon reducing the threshold, the network’s resilience to random attacks is correspondingly strengthened. Dynamically, from 2000 to 2022, systemic risk in significant industrial share markets significantly increased. From a static perspective, the period around 2019, affected by the COVID-19 pandemic, experienced the most drastic fluctuations. Compared to the year 2000, systemic risk entropy in 2022 increased nearly sixtyfold, further indicating an increasing instability within this complex network.

Open Access PDF

Concepts Keywords
China complex network
Pandemic stability
Pharmaceuticals stock market
Resilience systematic risk entropy

Semantics

Type Source Name
disease MESH COVID-19 pandemic
drug DRUGBANK Coenzyme M
disease IDO blood
disease VO Equity
disease VO time
disease VO ineffective
disease MESH causality
disease VO effective
disease MESH uncertainty
drug DRUGBANK Guanosine
disease VO effectiveness
disease VO frequency
disease IDO algorithm
disease VO volume
drug DRUGBANK Aspartame
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Diethylstilbestrol
drug DRUGBANK Ranitidine
drug DRUGBANK Trestolone
disease MESH shock
disease VO company
disease MESH unemployment
disease IDO country
disease VO organ
drug DRUGBANK Serine
drug DRUGBANK (S)-Des-Me-Ampa

Original Article

(Visited 2 times, 1 visits today)